Cardiac risk factors and adverse events among patients receiving first-line CLL treatment in a real-world community practice setting.

被引：0
|
作者：
Mato, Anthony R.
Tang, Boxiong
Azmi, Soraya
Yang, Keri
Wallis, Nicola
Stern, Jennifer C.
Hedrick, Eric
Huang, Jane
Sharman, Jeff Porter
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] BeiGene Ltd, Emeryville, CA USA
[3] BeiGene USA Inc, San Mateo, CA USA
[4] BeiGene Ltd, Cambridge, MA USA
[5] Willamette Valley Canc Inst, Eugene, OR USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e24044
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24044
引用
收藏
页数：3
相关论文
共 50 条
  • [1] First-line treatment patterns among patients with metastatic pancreatic ductal adenocarcinoma in the real-world setting
    Dennen, Syvart
    Harton, Joanna
    Cockrum, Paul
    Kim, George P.
    MacEwan, Joanna P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] First-Line Treatment Outcomes of CML Patients in a Real-World Data Setting in Lebanon
    Nasr, Fadi
    Yehia, Intissar
    El Khoury, Reem
    Diab, Saada
    Al Ghoche, Ahmad
    Nasr, Lewis
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S332 - S333
  • [3] Treatment patterns: Targeted therapies indicated for first-line management of metastatic renal cell carcinoma in a real-world setting.
    Hess, Gregory P.
    Borker, Rohit
    Fonseca, Eileen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [4] First-line treatment outcomes of CML patients in a real-world data setting in Lebanon.
    Nasr, Fadi
    Yehia, Intissar
    El Khoury, Reem
    Diab, Saada
    Ghoche, Ahmad
    Nasr, Lewis
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Atezolizumab in first-line treatment of metastatic nonsquamous non-small cell lung cancer in the real-world setting.
    De Castro, Javier
    Campos Balea, Begona
    Perez Parente, Diego
    Polito, Letizia
    Lawrance, Marcus
    Ruiz Gracia, Pedro
    Adler, Leah
    Marina Arroyo, Marta
    Socinski, Mark A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Real-World First-Line Treatment Patterns Among US Carcinoid Syndrome Patients
    Sun, Gordon H.
    Neary, Maureen P.
    Chang, Eunice
    Broder, Michael S.
    PANCREAS, 2015, 44 (02) : 359 - 360
  • [7] Real-World Comparison of Time to Next Treatment for Patients with CLL Initiated on First-Line Treatment with Ibrutinib Versus Acalabrutinib
    Jacobs, Ryan
    Lu, Xiaoxiao
    Emond, Bruno
    Morrison, Laura
    Kinkead, Frederic
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Khan, Wasiulla
    Wu, Linda
    Qureshi, Zaina P.
    Levy, Moshe Yair
    BLOOD, 2022, 140 : 1931 - 1933
  • [8] Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder
    Bartova, Lucie
    Fugger, Gernot
    Dold, Markus
    Kautzky, Alexander
    Fanelli, Giuseppe
    Zanardi, Raffaella
    Albani, Diego
    Weidenauer, Ana
    Rujescu, Dan
    Souery, Daniel
    Mendlewicz, Julien
    Montgomery, Stuart
    Zohar, Joseph
    Fabbri, Chiara
    Serretti, Alessandro
    Kasper, Siegfried
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 332 : 105 - 114
  • [9] Real-World Patterns of First-Line Hydroxyurea Treatment Among Patients with Essential Thrombocythemia in US Community Oncology Practices
    Yu, Jingbo
    Colucci, Philomena
    Paranagama, Dilan Chamikara
    Sivaraman, Smitha
    Atanasov, Pavel
    Hanna, Becky
    Tang, Jackson
    Parasuraman, Shreekant V.
    BLOOD, 2017, 130
  • [10] Real-world prevalence of adverse events with first-line systemic therapies among patients with metastatic castration-sensitive prostate cancer
    Swami, Umang
    Xie, Bin
    Young, Christopher
    Ramaswamy, Krishnan
    El-Chaar, Nader
    Gao, Wei
    Yang, Hongbo
    Wang, Yao
    Mucha, Lisa
    PROSTATE, 2024, 84 (15): : 1387 - 1397
12345